Myrjam De Keyser1, Maya De Belder2, Veva De Groot1,3. 1. Department of Medicine, University of Antwerp, Univer-siteitsplein 1, Antwerp B-2610, Belgium. 2. Department of Experimental Psychology, Ghent University, Henri Dunantlaan 2, Ghent B-9000, Belgium. 3. Department of Ophthalmology, University Hospital Antwerp, Wilrijkstraat 10, Edegem B-2650, Belgium.
Abstract
AIM: To compare quality of life and treatment satisfaction between patients who had selective laser trabeculoplasty (SLT) and those on medication. METHODS: A prospective clinical trial on 143 glaucoma patients that received SLT and a control group that continued using anti glaucoma medication was conducted. Tear break-up time (BUT), punctuate keratitis, need for help, use of artificial tears and the treatment satisfaction survey of intraocular pressure (IOP) were measured at baseline, 6 and 12mo. RESULTS: SLT was able to reduce the mean number of medications needed from 1.56±0.81 to 0.42±0.66 at six months and to 0.33±0.69 at one year. Punctuate keratitis was observed significantly less often (12.24%) after SLT than before (35.94%; P=0.03). Use of artificial tears and BUT did not change significantly after SLT (P>0.05). At baseline, patients in the SLT group were significantly less convinced of medication effectiveness (P=0.006) and complained more about side effects (P=0.003). After SLT, these patients had significantly more confidence in their therapy (P<0.001), showed less side effects (P=0.006), complained less about changes in appearance of the eyes (P=0.003) and were less inconvenienced by the use of eye drops (P<0.001). CONCLUSION: SLT is able to improve treatment-related quality of life in glaucoma patients.
AIM: To compare quality of life and treatment satisfaction between patients who had selective laser trabeculoplasty (SLT) and those on medication. METHODS: A prospective clinical trial on 143 glaucomapatients that received SLT and a control group that continued using anti glaucoma medication was conducted. Tear break-up time (BUT), punctuate keratitis, need for help, use of artificial tears and the treatment satisfaction survey of intraocular pressure (IOP) were measured at baseline, 6 and 12mo. RESULTS: SLT was able to reduce the mean number of medications needed from 1.56±0.81 to 0.42±0.66 at six months and to 0.33±0.69 at one year. Punctuate keratitis was observed significantly less often (12.24%) after SLT than before (35.94%; P=0.03). Use of artificial tears and BUT did not change significantly after SLT (P>0.05). At baseline, patients in the SLT group were significantly less convinced of medication effectiveness (P=0.006) and complained more about side effects (P=0.003). After SLT, these patients had significantly more confidence in their therapy (P<0.001), showed less side effects (P=0.006), complained less about changes in appearance of the eyes (P=0.003) and were less inconvenienced by the use of eye drops (P<0.001). CONCLUSION: SLT is able to improve treatment-related quality of life in glaucomapatients.
Entities:
Keywords:
glaucoma; laser treatment; medical treatment; quality of life
Authors: Louis B Cantor; L Jay Katz; J Wang Cheng; Er Chen; Kuo B Tong; John W Peabody Journal: Curr Med Res Opin Date: 2008-09-02 Impact factor: 2.580
Authors: Mandy Oi Man Wong; Jacky Wai Yip Lee; Bonnie Nga Kwan Choy; Jonathan Cheuk Hung Chan; Jimmy Shiu Ming Lai Journal: Surv Ophthalmol Date: 2014-07-02 Impact factor: 6.048
Authors: Amy M Bovell; Karim F Damji; William G Hodge; William J Rock; Ralf R Buhrmann; Yi I Pan Journal: Can J Ophthalmol Date: 2011-08-04 Impact factor: 1.882
Authors: Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti Journal: Bull World Health Organ Date: 2004-12-14 Impact factor: 9.408
Authors: Betsy L Sleath; R Krishnadas; Minhee Cho; Alan L Robin; Rakhi Mehta; David Covert; Gail Tudor Journal: Indian J Ophthalmol Date: 2009 Jan-Feb Impact factor: 1.848
Authors: Mark J Atkinson; William C Stewart; Joel M Fain; Jeanette A Stewart; Ravinder Dhawan; Essy Mozaffari; Jan Lohs Journal: Health Qual Life Outcomes Date: 2003-11-15 Impact factor: 3.186
Authors: Christiane R Rolim-de-Moura; Augusto Paranhos; Mohamed Loutfi; David Burton; Richard Wormald; Jennifer R Evans Journal: Cochrane Database Syst Rev Date: 2022-08-09